CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
6.98 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
6.98 |
Evidence |
O
|
EXOSC5 |
EXOSC5, CML28, RRP46: Exosome complex exonuclease RRP46 |
EXOSC8 |
EXOSC8, OIP2, RRP43: Exosome complex exonuclease RRP43 |
6.877 |
Evidence |
O
|
EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
EXOSC8 |
EXOSC8, OIP2, RRP43: Exosome complex exonuclease RRP43 |
6.877 |
Evidence |
|
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
ORC3L |
ORC3L, LATHEO: Origin recognition complex subunit 3 |
6.877 |
Evidence |
|
EXOSC4 |
EXOSC4, RRP41, SKI6: Exosome complex exonuclease RRP41 |
EXOSC8 |
EXOSC8, OIP2, RRP43: Exosome complex exonuclease RRP43 |
6.877 |
Evidence |
O
|
MCM7 |
MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 |
ORC3L |
ORC3L, LATHEO: Origin recognition complex subunit 3 |
6.877 |
Evidence |
|
ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
6.86 |
Evidence |
|
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
6.825 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CNN2 |
CNN2: Calponin-2 |
6.822 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
6.822 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
6.822 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
6.822 |
Evidence |
O
|
CCNB1 |
Cyclin B1 |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
6.822 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
PCAF |
PCAF: Histone acetyltransferase PCAF |
6.817 |
Evidence |
|
PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
PARD3 |
IPI00154915 |
6.817 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
6.817 |
Evidence |
|
CDK2 |
CDK2: Cell division protein kinase 2 |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
6.807 |
Evidence |
|
MYBL2 |
MYBL2, BMYB: Myb-related protein B |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
6.807 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
6.807 |
Evidence |
|
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
6.807 |
Evidence |
|
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
6.807 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
6.807 |
Evidence |
|
NID1 |
NID1, NID: Nidogen-1 precursor |
FBLN2 |
FBLN2: Fibulin-2 precursor |
6.782 |
Evidence |
|
TAF4 |
TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135: Transcription initiation factor |
TAF11 |
TAF11, TAF2I, PRO2134: Transcription initiation factor TFIID subunit 11 |
6.782 |
Evidence |
|